Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers
Eilean Therapeutics
Eilean Therapeutics
University of Turin, Italy
Peking Union Medical College Hospital
Ono Pharmaceutical Co. Ltd
Brigham and Women's Hospital
Hospices Civils de Lyon
PharmaEssentia
BeBetter Med Inc
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Gruppo Italiano Malattie EMatologiche dell'Adulto